Markets Rally Ahead of Trump’s Iran Address… And Fading The Bounce 4/1/26

Fast Money delivers a high-octane analysis of a volatile market rally fueled by anticipation of President Trump's address on the Middle East conflict, particularly the war in Iran. The episode opens with a strong market bounce, especially in tech and Nasdaq, but hosts express deep skepticism about its sustainability. Key concerns include elevated oil prices, persistent inflation, and structural issues in the market such as overvaluation, weak credit conditions, and a lack of genuine economic recovery. The discussion turns to Nike, whose shares plummeted over 15% after disappointing earnings and weak guidance, particularly due to a projected 20% revenue decline in China. Despite a bullish case from Guggenheim's Simeon Siegel, many on the panel remain skeptical, citing a 'whack-a-mole' management approach and a lack of clear turnaround. The episode also covers the potential for SpaceX's massive IPO, with a rumored $1.75 trillion valuation, and the growing competition in the weight-loss drug space, with Eli Lilly’s new oral drug Fundeo entering the market. A major theme is the premature nature of the rally, with guest Michael Kantopoulos warning of a 'bunker trade' strategy—raising cash while maintaining exposure to emerging markets and energy. The episode closes with a focus on Burlington's breakout potential and a final trade call on Viking Therapeutics, underscoring a cautious, selective optimism amid uncertainty.